Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenlixin granules in chronic kidney disease stage 4
CTR20130916Phase 2Active
- Sponsor
- Suzhou Youseen New Drug R&D
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rhein lysinate in chronic kidney disease (CKD), sponsored by Suzhou Youseen New Drug R&D. Started Oct 2013; status: active.
02
Drugs
rhein lysinate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20130916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130916.